Table 1 Characteristics of the overall population (HBOC), BRCA1 P/LPV carriers and BRCA2 P/LPV carriers

From: Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome

 

HBOC 87 patients

BRCA1 P/LPV carriers 32 patients

BRCA2 P/LPV carriers 47 patients

BRCA1 Vs BRCA2

 

Mean

SD

Miss.

Mean

SD

Miss.

Mean

SD

Miss.

p-value

Age

32.31

5.73

0

32.31

5.33

0

32.17

6.32

0

0.914

Hormonal contraceptive use (years)

5.76

5.72

40 (46%)

5.25

5.22

12 (38%)

5.67

6.50

25 (53%)

0.819

Menarche (years)

12.26

1.48

0

11.95

1.40

0

12.40

1.54

0

0.182

Length of menstrual cycle (days)

28.18

2.35

9 (10%)

28.10

2.11

3 (9%)

28.14

2.66

5 (11%)

0.945

BMI

23.52

4.39

1 (1%)

23.98

3.88

0

22.94

4.81

1 (2%)

0.292

AMH (ng/ml)

2.62

1.86

1 (1%)

2.92

2.06

0

2.43

1.75

1 (2%)

0.278

AFC (n)

16.20

9.97

2 (2%)

16.06

9.02

0

15.98

10.96

2 (4%)

0.971

 

N

Perc.

Miss.

N

Perc.

Miss.

N

Perc.

Miss.

 

Previous pregnancies (n)

  

0

  

0

  

0

0.946

0

44

50.57

 

16

50.00

 

25

53.19

  

1

13

14.94

 

5

15.63

 

7

14.89

  

2

21

24.14

 

9

28.13

 

10

21.28

  

3

5

5.75

 

1

3.13

 

3

6.38

  

4

4

4.60

 

1

3.13

 

2

4.26

  

Previous deliveries (n)

  

0

  

0

  

0

0.936

0

48

55.17

 

18

56.25

 

26

55.32

  

1

16

18.39

 

6

18.75

 

9

19.15

  

2

19

21.84

 

7

21.88

 

9

19.15

  

3

3

3,45

 

1

3.13

 

2

4.26

  

4

1

1.15

 

0

0.00

 

1

2.13

  

Previous termination of pregnancy (n)

  

0

  

0

  

0

0.883

0

70

80.46

 

26

81.25

 

40

85.11

  

1

12

13.79

 

5

15.63

 

5

10.64

  

2

5

5.75

 

1

3.13

 

2

4.26

  

Current smoking

  

0

  

0

  

0

0.518

No

71

81.61

 

24

75.00

 

40

85.11

  

Yes

16

18.39

 

8

25.00

 

7

14.89

  

Family history of premature menopause

  

0

  

0

  

0

0,178

No

80

91.95

 

29

90.63

 

43

91.49

  

Yes

7

8.05

 

3

9.38

 

4

8.51

  

Prophylactic surgery

  

0

  

0

  

0

1,000

None

79

90.80

 

28

87.50

 

43

91.49

  

Mastectomy

6

6.90

 

3

9.38

 

3

6.38

  

Salpingectomy

1

1.15

 

0

0.00

 

1

2.13

  

Mastectomy and salpingectomy

1

1,.15

 

1

3.13

 

0

0.00

  
  1. AFC antral follicle count, AMH anti-mullerian hormone, BMI body mass index, HBOC hereditary breast and/or ovarian cancer, Miss missing, Per percentage, P/LPV pathogenic/likely pathogenic variants. SD standard deviation.